NTLA
NTLA
US45826J1051
Intellia Therapeutics, Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
1.83B EUR
2.37B EUR
1.54B EUR
1.05B EUR
Enterprise Value
1.4B EUR
2.34B EUR
1.49B EUR
983.56M EUR
Valuation Multiples
Trailing P/E
--
--
--
--
Forward P/E
-5.09x
--
--
--
Price to Sales
30.78x
39.81x
23.36x
20.49x
Price to Book
2.51x
3.26x
2.49x
1.56x
EV/Revenue
23.55x
39.26x
22.54x
19.27x
EV/EBITDA
-3.38x
--
--
--
Price to FCF (P/FCF)
--
--
--
--
EV/FCF
--
--
--
--
FCF Yield
-13.64%
-14.72%
-23.55%
-23.54%
ende